CenterBook Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-836
Closed -$326K – 939
2026
Q2
$326K Buy
+836
New +$353K 0.02% 613
2025
Q4
– Sell
-1,193
Closed -$508K – 608
2025
Q3
$508K Sell
1,193
-782
-40% -$303K 0.03% 476
2025
Q2
$757K Sell
1,975
-1,245
-39% -$449K 0.04% 367
2025
Q1
$1.11M Sell
3,220
-3,318
-51% -$1.07M 0.07% 302
2024
Q4
$1.96M Buy
+6,538
New +$2.28M 0.12% 208
2024
Q3
– Sell
-3,845
Closed -$1.24M – 485
2024
Q2
$1.24M Buy
3,845
+129
+3% +$41.9K 0.08% 315
2024
Q1
$1.24M Sell
3,716
-1,255
-25% -$384K 0.09% 294
2023
Q4
$1.35M Sell
4,971
-2,345
-32% -$580K 0.16% 209
2023
Q3
$1.8M Buy
7,316
+6,306
+624% +$1.73M 0.22% 152
2023
Q2
$307K Sell
1,010
-3,994
-80% -$1.11M 0.04% 371
2023
Q1
$1.32M Sell
5,004
-9,252
-65% -$2.35M 0.19% 177
2022
Q4
$3.42M Buy
14,256
+1,176
+9% +$263K 0.56% 36
2022
Q3
$2.4M Buy
13,080
+1,116
+9% +$222K 0.46% 58
2022
Q2
$2.01M Buy
11,964
+9,944
+492% +$2.14M 0.43% 62
2022
Q1
$506K Buy
2,020
+701
+53% +$176K 0.18% 206
2021
Q4
$339K Buy
+1,319
New +$323K 0.2% 185

Other funds holding HCA

CenterBook Partners's HCA Position: Q3 2026 in Review

CenterBook Partners sold out of HCA Healthcare (HCA) in Q3 2026, closing a stake of 836 shares — an estimated $326K sold.

CenterBook Partners first reported a position in HCA in Q4 2021 and held it in 16 quarters. The position peaked at $3.42M in Q4 2022. 1,183 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • CenterBook Partners reported no remaining HCA Healthcare position as of Q3 2026 after selling out during the quarter.
  • CenterBook Partners sold 836 HCA Healthcare shares in Q3 2026, an estimated $326K.
  • CenterBook Partners first reported a position in HCA Healthcare in Q4 2021 and held it in 16 quarters.
  • CenterBook Partners's HCA Healthcare position peaked at $3.42M in Q4 2022.
  • 1,183 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.